Business Wire India
Union Minister of State of Science and Technology, Earth Sciences, and Prime Minister’s Office Dr Jitendra Singh gave away the prestigious National Technology Awards 2022 for the successful commercialization of indigenous technologies on National Science Day 2022.
Sahajanand Medical Technologies Limited bagged the National Technology Award 2022 for Supraflex Cruz - Sirolimus Eluting Coronary System.
Speaking at the National Technology Day 2022 event, which coincides with India becoming a full Nuclear Country after the Nuclear explosion at Pokhran on 11th May, 1998, Dr Jitendra Singh said, “India is already on the ascent and Science, Technology and Innovation are going to be the key determinants of the roadmap for next 25 years when we celebrate 100 years of India’s Independence.”
The awards were given by the Technology Development Board (TDB), a statutory body of Government of India functioning under Department of Science of Technology for the year 2021-22. The winners were selected from a total 390 applications after thorough examination by eminent technologists and a stringent two-tier evaluation process. The winners have been selected under the categories --Indigenous Technologies, MSME, Startups, and Women Scientists in Translational Research and Women Entrepreneurs. Dr S. Chandrasekhar, Secretary, DST and Shri Rajesh Kumar Pathak, IP&TAFS, Secretary TDB were Guests of Honours.
“These awards conferred to various industries provides a platform of recognition to Indian industries and their technology provider, who have worked as a team, to bring innovation to the market and contributed to the vision of “Aatma Nirbhar Bharat”," said Shri Rajesh Kumar Pathak, IP&TAFS, Secretary, Technology Development Board.
‘Supraflex Cruz’ is a Drug Eluting Coronary Stent with features such as low strut thickness (60 microns across all diameters), biodegradable polymer and is offered in many sizes. It is considered to be the “most deliverable” stent (Source: Frost & Sullivan’s report on “Independent Market Report on Vascular Devices Market in Select Geographies” dated August 20, 2021). Deliverability implies high ‘ease of use’ for implanting physicians in deploying a stent into complex arteries. Supraflex Cruz has been implanted in more than 400,000 patients globally as of March 31, 2021.
Congratulating the winners Dr VK Rai, Head of the Scientific Award Conduction Committee and Scientist - 'F' at Technology Development Board said, "This award is the most prestigious award in the field of Science and Technology. I congratulate Sahajanand Medical Technologies Ltd for successful commercialisation of the indigenously developed Supraflex Cruz - Sirolimus Eluting Coronary System, as a recognition of self-reliant India.”
Accepting the honour Mr Bhargav Kotadia, Managing Director, Sahajanand Medical Technologies Limited ("SMT”) said, “We are proud to receive this coveted award from the Government of India, recognising SMT’s position as a leading technology provider in the vascular devices domain globally. Since inception SMT has followed its motto ‘Pledged to Save Millions’, and with our unique and rigorously tested products, we proudly take forward the Hon’ble Prime Ministers vision of a ‘Self-Reliant’ India, ridding import dependency in this niche segment of vascular products.”
